Eli Lilly (LLY) Intangibles (2013 - 2026)
Eli Lilly's Intangibles came in at $18.08 billion for Q3 2026, up 180.5% from $6.45 billion a year earlier but down 0.1% from the prior quarter.
Powered by 
Analysis
Eli Lilly (LLY) Intangibles (2013 - 2026) Analysis & Trends
At the end of FY2025, Eli Lilly's Intangibles was $6.52 billion, up 5.8% from FY2024.
- Intangibles carries a five-year compound annual growth rate of -2.6% (FY2020 to FY2025).
- Going back by year, Intangibles was $6.17 billion in FY2024 (-10.7%), $6.91 billion in FY2023 (-4.2%), $7.21 billion in FY2022 (-6.3%) and $7.69 billion in FY2021 (+3.2%).
- The five-year range for quarterly Intangibles is $5.91 billion (Q2 2025) to $18.11 billion (Q2 2026).
- Year-over-year, Intangibles has increased for four consecutive quarters, with growth averaging 47.7% over the last eight quarters.
- The fastest year-over-year change in Intangibles over five years came in Q2 2026 (growth of 206.5%), and the weakest in Q1 2025 (a decline of 11.1%).
- Business Quant data shows LLY's Intangibles at $18.11 billion (Q2 2026), $7.37 billion (Q1 2026) and $6.52 billion (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 18.08 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 46.65 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 56.65 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 24.48 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 42.07 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 37.72 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 19.54 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 13.42 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 45.96 Bn |
| 10 | Vertex Pharmaceuticals | 138.78 Bn | 110.77 Bn | 2.91 Bn | 8.52 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 18.08 Bn |
| Jun 30, 2026 | 18.11 Bn |
| Mar 31, 2026 | 7.37 Bn |
| Dec 31, 2025 | 6.52 Bn |
| Sep 30, 2025 | 6.45 Bn |
| Jun 30, 2025 | 5.91 Bn |
| Mar 31, 2025 | 6.01 Bn |
| Dec 31, 2024 | 6.17 Bn |
| Sep 30, 2024 | 6.54 Bn |
| Jun 30, 2024 | 6.64 Bn |
| Mar 31, 2024 | 6.76 Bn |
| Dec 31, 2023 | 6.91 Bn |
| Sep 30, 2023 | 6.78 Bn |
| Jun 30, 2023 | 6.90 Bn |
| Mar 31, 2023 | 7.09 Bn |
| Dec 31, 2022 | 7.21 Bn |
| Sep 30, 2022 | 7.12 Bn |
| Jun 30, 2022 | 7.50 Bn |
| Mar 31, 2022 | 7.48 Bn |
| Dec 31, 2021 | 7.69 Bn |
API Access
Eli Lilly Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=LLY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "LLY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=LLY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();